Clinical Trials | February 11, 2026
Veradermics completes enrollment in both Phase 3 male hair loss trials
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
The milestone means more than 1,000 men are now enrolled across both Phase 3 programs
Subscribe To Our Newsletter & Stay Updated